Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors

OncoImmunology

Volumn 2, Issue 2, 2013, Pages

  Lerret, Nadine M ^a   Marzo, Amanda L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adoptive T cell therapy; CD8 T cells; Low dose irradiation; Mammaglobin A; Tumor eradication

Indexed keywords

CD27 ANTIGEN; DNA VACCINE; HLA A2 ANTIGEN; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MACROPHAGE SCAVENGER RECEPTOR 1; MAMMAGLOBIN A EPITOPE ENCODING DNA VACCINE; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE T CELL TRANSFER; ADOPTIVE TRANSFER; BREAST TUMOR; CANCER CONTROL; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL MEMORY T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR MEMORY T LYMPHOCYTE; MEMORY T LYMPHOCYTE; NONHUMAN; NOTE; PRIORITY JOURNAL; RADIATION DOSE; TUMOR IMMUNITY; TUMOR RECURRENCE; TUMOR REGRESSION; WHOLE BODY RADIATION;

EID: 84886944818     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22731     Document Type: Note

References (8)

1. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 1999; 59:3028-31; PMID:10397237.
2. Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, Hansen TH, et al. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat 2004; 88:29-41; PMID:15538043; http://dx.doi.org/10.1007/s10549-004-8918-1.
3. Melief CJ. Cancer immunotherapy by dendritic cells. Immunity 2008; 29:372-83; PMID:18799145; http://dx.doi.org/10.1016/j.immuni.2008.08.004.
4. Plate J. Clinical trials of vaccines for immunotherapy in pancreatic cancer. Expert Rev Vaccines 2011; 10:825-36; PMID:21692703; http://dx.doi.org/10.1586/erv.11.77.
5. Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, et al. Toll-like receptors in tumor immunotherapy. Clin Cancer Res 2007; 13:5280-9; PMID:17875756; http://dx.doi.org/10.1158/1078-0432.CCR-07-1378.
6. Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 2005; 202:907-12; PMID:16203864; http://dx.doi.org/10.1084/jem.20050732.
7. Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest 2007; 117:2197-204; PMID:17657310; http://dx.doi.org/10.1172/JCI32205.
8. Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 2010; 16:880-6; PMID:20622859; http://dx.doi.org/10.1038/nm.2172.